ACRO BIOMEDICAL CO., LTD. Diluted Shares Outstanding (Weighted Average)
ACRO BIOMEDICAL CO., LTD. (ACBM) reported Diluted Shares Outstanding (Weighted Average) of 60.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 60.04M shares, a 0.00% change year-over-year.
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 60.04M shares, a 0.00% change year-over-year.
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 60.04M shares, a 0.00% change year-over-year.
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 60.04M shares, a 0.00% change year-over-year.
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for fiscal 2025 was 60.04M shares, a 0.00% change from fiscal 2024.
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for fiscal 2024 was 60.04M shares, a 0.00% change from fiscal 2023.
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for fiscal 2023 was 60.04M shares, a 0.00% change from fiscal 2022.
- ACRO BIOMEDICAL CO., LTD. weighted average number of shares outstanding, diluted for fiscal 2022 was 60.04M shares, a 11.52% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 60.04M shares 10-Q · filed 2026-08-14 | 60.04M shares 10-Q · filed 2026-08-14 | 60.04M shares derived: average of 3 quarters · filed 2026-08-14 | 60.04M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 60.04M shares 10-Q · filed 2026-05-05 | 60.04M shares derived: average of 2 quarters · filed 2026-05-05 | 60.04M shares derived: average of 3 quarters · filed 2026-05-05 | 60.04M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 60.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | 60.04M shares derived: average of 2 quarters · filed 2026-02-11 | 60.04M shares derived: average of 3 quarters · filed 2026-08-14 | 60.04M shares 10-K · filed 2026-02-11 |
| 2025-09-30 | 60.04M shares 10-Q · filed 2025-11-10 | 60.04M shares derived: average of 2 quarters · filed 2026-08-14 | 60.04M shares 10-Q · filed 2025-11-10 | 60.04M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 60.04M shares 10-Q · filed 2026-08-14 | 60.04M shares 10-Q · filed 2026-08-14 | 60.04M shares derived: average of 3 quarters · filed 2026-08-14 | 60.04M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 60.04M shares 10-Q · filed 2026-05-05 | 60.04M shares derived: average of 2 quarters · filed 2026-05-05 | 60.04M shares derived: average of 3 quarters · filed 2026-05-05 | 60.04M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 60.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | 60.04M shares derived: average of 2 quarters · filed 2026-02-11 | 60.04M shares derived: average of 3 quarters · filed 2026-02-11 | 60.04M shares 10-K · filed 2026-02-11 |
| 2024-09-30 | 60.04M shares 10-Q · filed 2025-11-10 | 60.04M shares derived: average of 2 quarters · filed 2025-11-10 | 60.04M shares 10-Q · filed 2025-11-10 | 60.04M shares derived: average of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | 60.04M shares 10-Q · filed 2025-08-05 | 60.04M shares 10-Q · filed 2025-08-05 | 60.04M shares derived: average of 3 quarters · filed 2025-08-05 | 60.04M shares derived: average of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | 60.04M shares 10-Q · filed 2025-07-24 | 60.04M shares derived: average of 2 quarters · filed 2025-07-24 | 60.04M shares derived: average of 3 quarters · filed 2025-07-24 | 60.04M shares derived: average of 4 quarters · filed 2025-07-24 |
| 2023-12-31 | 60.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | 60.04M shares derived: average of 2 quarters · filed 2025-07-24 | 60.04M shares derived: average of 3 quarters · filed 2025-07-24 | 60.04M shares 10-K · filed 2025-07-24 |
| 2023-09-30 | 60.04M shares 10-Q · filed 2025-07-23 | 60.04M shares derived: average of 2 quarters · filed 2025-07-23 | 60.04M shares 10-Q · filed 2025-07-23 | 60.04M shares derived: average of 4 quarters · filed 2025-07-23 |
| 2023-06-30 | 60.04M shares 10-Q · filed 2025-07-23 | 60.04M shares 10-Q · filed 2025-07-23 | 60.04M shares derived: average of 3 quarters · filed 2025-07-23 | 60.04M shares derived: average of 4 quarters · filed 2025-07-23 |
| 2023-03-31 | 60.04M shares 10-Q · filed 2025-07-22 | 60.04M shares derived: average of 2 quarters · filed 2025-07-22 | 60.04M shares derived: average of 3 quarters · filed 2025-07-22 | |
| 2022-12-31 | 60.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | 60.04M shares derived: average of 2 quarters · filed 2025-07-18 | 60.04M shares 10-K · filed 2025-07-18 | |
| 2022-09-30 | 60.04M shares 10-Q · filed 2025-07-11 | 60.04M shares 10-Q · filed 2025-07-11 | ||
| 2021-12-31 | 53.84M shares 10-K · filed 2022-04-15 | |||
| 2020-12-31 | 47.76M shares 10-K · filed 2022-04-15 |